CPD
Carboxypeptidase D
Also known as: CBPD_HUMAN, GP180
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75976
- Gene
- CPD
- Ensembl
- ENSG00000108582
- Chromosome
- 17
- Canonical length
- 1380 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The metallocarboxypeptidase family of enzymes is divided into 2 subfamilies based on sequence similarities. The pancreatic carboxypeptidase-like and the regulatory B-type carboxypeptidase subfamilies. Carboxypeptidase D has been identified as a regulatory B-type carboxypeptidase. CPD is a homolog of duck gp180, a hepatitis B virus-binding protein. Transcript variants utilizing alternative polyadenylation signals exist for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1380 residues, UniProt reviewed canonical sequence.
>O75976|CPD
1 MASGRDERPP WRLGRLLLLM CLLLLGSSAR AAHIKKAEAT TTTTSAGAEA AEGQFDRYYH
61 EEELESALRE AAAAGLPGLA RLFSIGRSVE GRPLWVLRLT AGLGSLIPEG DAGPDAAGPD
121 AAGPLLPGRP QVKLVGNMHG DETVSRQVLI YLARELAAGY RRGDPRLVRL LNTTDVYLLP
181 SLNPDGFERA REGDCGFGDG GPSGASGRDN SRGRDLNRSF PDQFSTGEPP ALDEVPEVRA
241 LIEWIRRNKF VLSGNLHGGS VVASYPFDDS PEHKATGIYS KTSDDEVFKY LAKAYASNHP
301 IMKTGEPHCP GDEDETFKDG ITNGAHWYDV EGGMQDYNYV WANCFEITLE LSCCKYPPAS
361 QLRQEWENNR ESLITLIEKV HIGVKGFVKD SITGSGLENA TISVAGINHN ITTGRFGDFY
421 RLLVPGTYNL TVVLTGYMPL TVTNVVVKEG PATEVDFSLR PTVTSVIPDT TEAVSTASTV
481 AIPNILSGTS SSYQPIQPKD FHHHHFPDME IFLRRFANEY PNITRLYSLG KSVESRELYV
541 MEISDNPGVH EPGEPEFKYI GNMHGNEVVG RELLLNLIEY LCKNFGTDPE VTDLVHNTRI
601 HLMPSMNPDG YEKSQEGDSI SVIGRNNSNN FDLNRNFPDQ FVQITDPTQP ETIAVMSWMK
661 SYPFVLSANL HGGSLVVNYP FDDDEQGLAT YSKSPDDAVF QQIALSYSKE NSQMFQGRPC
721 KNMYPNEYFP HGITNGASWY NVPGGMQDWN YLQTNCFEVT IELGCVKYPL EKELPNFWEQ
781 NRRSLIQFMK QVHQGVRGFV LDATDGRGIL NATISVAEIN HPVTTYKTGD YWRLLVPGTY
841 KITASARGYN PVTKNVTVKS EGAIQVNFTL VRSSTDSNNE SKKGKGASSS TNDASDPTTK
901 EFETLIKDLS AENGLESLML RSSSNLALAL YRYHSYKDLS EFLRGLVMNY PHITNLTNLG
961 QSTEYRHIWS LEISNKPNVS EPEEPKIRFV AGIHGNAPVG TELLLALAEF LCLNYKKNPA
1021 VTQLVDRTRI VIVPSLNPDG RERAQEKDCT SKIGQTNARG KDLDTDFTNN ASQPETKAII
1081 ENLIQKQDFS LSVALDGGSM LVTYPYDKPV QTVENKETLK HLASLYANNH PSMHMGQPSC
1141 PNKSDENIPG GVMRGAEWHS HLGSMKDYSV TYGHCPEITV YTSCCYFPSA ARLPSLWADN
1201 KRSLLSMLVE VHKGVHGFVK DKTGKPISKA VIVLNEGIKV QTKEGGYFHV LLAPGVHNII
1261 AIADGYQQQH SQVFVHHDAA SSVVIVFDTD NRIFGLPREL VVTVSGATMS ALILTACIIW
1321 CICSIKSNRH KDGFHRLRQH HDEYEDEIRM MSTGSKKSLL SHEFQDETDT EEETLYSSKHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CPD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 54 nTPM
- salivary gland: 42 nTPM
- testis: 39 nTPM
- cervix: 39 nTPM
- stomach: 35 nTPM
- bone marrow: 30 nTPM
Single-cell type
- neutrophils: 3,286 nCPM
- salivary acinar cells: 364 nCPM
- lacrimal acinar cells: 311 nCPM
- neutrophil progenitors: 271 nCPM
- monocytes: 212 nCPM
- salivary myoepithelial cells: 188 nCPM
Immune cell
- neutrophil: 25 nTPM
- eosinophil: 8.4 nTPM
- classical monocyte: 7.7 nTPM
- basophil: 4.5 nTPM
- MAIT T-cell: 4.5 nTPM
- myeloid DC: 4.4 nTPM
Brain region
- white matter: 65 nTPM
- cerebral cortex: 64 nTPM
- medulla oblongata: 50 nTPM
- spinal cord: 48 nTPM
- pons: 44 nTPM
- cerebellum: 41 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.59
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase M14, carboxypeptidase A
- Carboxypeptidase-like, regulatory domain superfamily
- Peptidase M14 domain-containing protein
- Zinc carboxypeptidases, zinc-binding region 1
- Zinc carboxypeptidases, zinc-binding region 2
- Zinc carboxypeptidase
- Carboxypeptidase regulatory-like domain
- Carboxypeptidase D, carboxypeptidase-like domain 3
- Carboxypeptidase D, carboxypeptidase-like domain 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CPD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CPD as an antibody target. Whether an autoantibody or antibody against CPD could matter depends on whether native CPD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CPD is annotated at the cell surface, where native CPD is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CPD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...